545 related articles for article (PubMed ID: 15254333)
1. Development of a peptide reactivity assay for screening contact allergens.
Gerberick GF; Vassallo JD; Bailey RE; Chaney JG; Morrall SW; Lepoittevin JP
Toxicol Sci; 2004 Oct; 81(2):332-43. PubMed ID: 15254333
[TBL] [Abstract][Full Text] [Related]
2. Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach.
Gerberick GF; Vassallo JD; Foertsch LM; Price BB; Chaney JG; Lepoittevin JP
Toxicol Sci; 2007 Jun; 97(2):417-27. PubMed ID: 17400584
[TBL] [Abstract][Full Text] [Related]
3. A chemical dataset for evaluation of alternative approaches to skin-sensitization testing.
Gerberick GF; Ryan CA; Kern PS; Dearman RJ; Kimber I; Patlewicz GY; Basketter DA
Contact Dermatitis; 2004 May; 50(5):274-88. PubMed ID: 15209809
[TBL] [Abstract][Full Text] [Related]
4. The incorporation of lysine into the peroxidase peptide reactivity assay for skin sensitization assessments.
Troutman JA; Foertsch LM; Kern PS; Dai HJ; Quijano M; Dobson RL; Lalko JF; Lepoittevin JP; Gerberick GF
Toxicol Sci; 2011 Aug; 122(2):422-36. PubMed ID: 21555337
[TBL] [Abstract][Full Text] [Related]
5. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
[TBL] [Abstract][Full Text] [Related]
6. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
[TBL] [Abstract][Full Text] [Related]
7. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
Gerberick GF; Ryan CA; Dearman RJ; Kimber I
Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
[TBL] [Abstract][Full Text] [Related]
8. Contact allergenic potency: correlation of human and local lymph node assay data.
Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
[TBL] [Abstract][Full Text] [Related]
10. Non-enzymatic glutathione reactivity and in vitro toxicity: a non-animal approach to skin sensitization.
Aptula AO; Patlewicz G; Roberts DW; Schultz TW
Toxicol In Vitro; 2006 Mar; 20(2):239-47. PubMed ID: 16112535
[TBL] [Abstract][Full Text] [Related]
11. Investigation of surface plasmon resonance biosensor for skin sensitizers studies.
Achilleos C; Tailhardat M; Courtellemont P; Varlet BL; Dupont D
Toxicol In Vitro; 2009 Mar; 23(2):308-18. PubMed ID: 19073248
[TBL] [Abstract][Full Text] [Related]
12. Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods.
Gerberick GF; Ryan CA; Kern PS; Schlatter H; Dearman RJ; Kimber I; Patlewicz GY; Basketter DA
Dermatitis; 2005 Dec; 16(4):157-202. PubMed ID: 16536334
[TBL] [Abstract][Full Text] [Related]
13. Identification of metal allergens in the local lymph node assay.
Basketter DA; Lea LJ; Cooper KJ; Ryan CA; Gerberick GF; Dearman RJ; Kimber I
Am J Contact Dermat; 1999 Dec; 10(4):207-12. PubMed ID: 10594296
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of skin sensitization potency of acrylates (methyl acrylate, ethyl acrylate, butyl acrylate, and ethylhexyl acrylate) using the local lymph node assay.
Dearman RJ; Betts CJ; Farr C; McLaughlin J; Berdasco N; Wiench K; Kimber I
Contact Dermatitis; 2007 Oct; 57(4):242-7. PubMed ID: 17868217
[TBL] [Abstract][Full Text] [Related]
15. Does irritation potency contribute to the skin sensitization potency of contact allergens?
Basketter DA; Kan-King-Yu D; Dierkes P; Jowsey IR
Cutan Ocul Toxicol; 2007; 26(4):279-86. PubMed ID: 18058302
[TBL] [Abstract][Full Text] [Related]
16. Nothing is perfect, not even the local lymph node assay: a commentary and the implications for REACH.
Basketter DA; McFadden JF; Gerberick F; Cockshott A; Kimber I
Contact Dermatitis; 2009 Feb; 60(2):65-9. PubMed ID: 19207375
[TBL] [Abstract][Full Text] [Related]
17. Reactivity profiling: covalent modification of single nucleophile peptides for skin sensitization risk assessment.
Aleksic M; Thain E; Roger D; Saib O; Davies M; Li J; Aptula A; Zazzeroni R
Toxicol Sci; 2009 Apr; 108(2):401-11. PubMed ID: 19221146
[TBL] [Abstract][Full Text] [Related]
18. LC-MS-based characterization of the peptide reactivity of chemicals to improve the in vitro prediction of the skin sensitization potential.
Natsch A; Gfeller H
Toxicol Sci; 2008 Dec; 106(2):464-78. PubMed ID: 18791182
[TBL] [Abstract][Full Text] [Related]
19. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
Schneider K; Akkan Z
Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
[TBL] [Abstract][Full Text] [Related]
20. The local lymph node assay and skin sensitization testing.
Kimber I; Dearman RJ
Methods Mol Biol; 2010; 598():221-31. PubMed ID: 19967517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
